The Sputnik V vaccine was developed by Russia's Gamaleya Research Institute. Photo: Serg Zastavkin/Shutterstock
Brazilian health regulator Anvisa will send a team to Russia to inspect the Sputnik V vaccine’s production lines. The move comes after President Jair Bolsonaro changed this tune on the Russian vaccine and began pressuring Anvisa to give it a go.
Until recently, Mr. Bolsonaro said he would not purchase any vaccines not approved by regulators. That stance began changing on Tuesday, after he spoke on the telephone with Russian President Vladimir Putin.
Anvisa Chairman Antônio Barra Torres took part in the call. Afterward, the agency promised that it would be “more proactive” in the path toward approving Sputnik V. Brasília correspondent Renato Alves explained the U-turn in detail.
The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…
Pelé, Ronaldo, Zico, Marta … All of Brazil’s truly immortal sporting icons are footballers, that…
Speaking before a Senate hearing on Tuesday, Chief of Staff Rui Costa admitted that Brazil…
New job market data from the Brazilian Institute of Geography and Statistics (IBGE) show the…
Brazil officially had 5.83 million domestic workers in 2022 — almost the entire population of…
Brazil’s Ministry of Health this month announced a purchase of 12.5 million doses of Moderna’s…